The World Health Organization has renewed its Science Council, appointing 21 scientists and experts to advise the agency on emerging technologies and high-priority questions that could affect global health.
WHO announced the new membership on August 27, 2026. The group includes specialists in public health, epidemiology, biomedical research, health systems, ageing, engineering, precision medicine and emerging technologies. Members come from all WHO regions, and two seats are held by youth representatives.
What the WHO Science Council actually does
The Science Council is an external advisory body rather than a regulator or a research laboratory. It advises the WHO Director-General on scientific developments that may require international attention, and it helps the organization decide which research and innovation questions deserve priority.
According to the council’s terms of work, its responsibilities include evaluating urgent scientific issues, identifying new technologies and health threats, guiding WHO’s science strategy and reviewing selected technical products when requested. Its members serve in their personal capacities, which means they are expected to provide independent expertise rather than formally represent their employers or governments.
The council was created in 2021 as part of a broader effort to strengthen WHO’s ability to turn scientific evidence into public-health guidance. The renewed membership continues that role at a time when health institutions are trying to assess fast-moving developments without overstating either their promise or their risks.
Why emerging technology is central to the new term
WHO Director-General Dr. Tedros Adhanom Ghebreyesus pointed to artificial intelligence, biotechnology, gene editing, synthetic biology and robotics as examples of fields advancing quickly. Each could improve prevention, diagnosis or treatment, but each also raises practical questions about safety, access, evidence and governance.
For example, an AI system may perform well in a well-funded hospital but fail when used with different populations or limited infrastructure. A genetic technology may show scientific promise while remaining too expensive for the countries carrying the greatest burden of disease. Robotics may expand access to specialized care, yet require reliable power, connectivity, training and maintenance.
The council’s value will therefore depend on more than spotting impressive inventions. It must help WHO separate early evidence from hype, identify where standards are needed and consider whether benefits can reach people across very different health systems.
A deliberately broad range of expertise
The new council includes experts working across basic science, clinical research, epidemiology, public health implementation, biomedical engineering, health economics and health policy. That breadth matters because a breakthrough does not move from a laboratory to better health outcomes through science alone.
New tools also need clinical validation, ethical safeguards, trained workers, financing, supply chains and public trust. A council made up only of laboratory researchers could miss implementation problems; a body focused only on policy could underestimate the technical limits of a new approach.
WHO says the membership was selected with geographic diversity, gender balance and generational representation in mind. The two youth members are intended to bring perspectives from people who will live longest with the policy choices made around today’s emerging technologies.
What the appointment does—and does not—mean
The announcement does not approve a new medicine, certify an AI product or change national health policy by itself. The council provides advice. Formal WHO recommendations still depend on evidence reviews, expert processes and the agency’s established decision-making structures.
That distinction is important. Scientific advisory bodies can help institutions prepare for change, but they do not eliminate uncertainty. Their usefulness comes from asking difficult questions early, making assumptions visible and explaining where evidence is strong, incomplete or disputed.
The council’s previous work has addressed topics including responsible use of digital technologies in global health, access to genomics and the potential and limitations of mRNA technology. Those subjects show the kind of long-range questions the renewed group may continue to examine.
What to watch next
WHO has not tied the new appointments to a single immediate decision. The next meaningful signals will be the priorities the council chooses, the reports it produces and whether its advice results in practical guidance that countries can use.
The central test is straightforward: can the council help WHO recognize genuinely transformative science early while protecting equity, safety and trust? With health technology moving quickly, independent advice will matter most when it is transparent about both opportunity and uncertainty.
Sources: WHO’s August 27 announcement; WHO Science Council overview and membership. Featured image: original editorial illustration created for Smashology Media.
Edin Pula
Edin Pula is the editor responsible for reviewing and publishing content at Smashology Media. He oversees sourcing, fact-checking, corrections, and editorial standards across coverage of internet culture, technology, entertainment, news, and crime.
